Breaking News

U.K. Terror Threat Level Raised to Severe From Substantial
Tweet TWEET

Law Firm Brower Piven Announces Investigation of BioClinica, Inc.

  Law Firm Brower Piven Announces Investigation of BioClinica, Inc.

Business Wire

STEVENSON, Md. -- January 31, 2013

The securities litigation firm of Brower Piven, A Professional Corporation,
has commenced an investigation into possible breaches of fiduciary duty to
current shareholders of BioClinica, Inc. (“BioClinica” or the “Company”)
(Nasdaq: “BIOC”) and other violations of state law by the board of directors
of BioClinica relating to the proposed acquisition of the Company by private
equity firm JLL Partners, Inc. The firm’s investigation seeks to determine,
among other things, whether the board of directors of BioClinica breached
their fiduciary duties by failing to maximize shareholder value.

Under the terms of the proposed transaction, BioClinica shareholders will
receive $7.25 in cash for each share of common stock they own. The transaction
is currently being valued at approximately $123 million. According to Yahoo!
Finance, the median and high analyst price target was $9.00 per BioClinica
share just prior to the announcement of the proposed transaction.

If you currently own common stock of BioClinica and would like to learn more
about the investigation being conducted by Brower Piven, you may email or call
Brower Piven, who will, without obligation or cost to you, attempt to answer
your questions. You may contact Brower Piven by email at
hoffman@browerpiven.com, by calling (410) 415-6616, or at Brower Piven, A
Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153.
Attorneys at Brower Piven have combined experience litigating securities and
other class action cases of over 60 years.

Contact:

Brower Piven, A Professional Corporation
Stevenson, Maryland
Charles J. Piven, 410-415-6616
hoffman@browerpiven.com
 
Press spacebar to pause and continue. Press esc to stop.